Figs Inc. (FIGS)
NYSE NYSE Primary 
Figs (FIGS) Moves to Strong Buy: Rationale Behind the Upgrade
Figs (FIGS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
FIGS, MDB, and More Are Now Strong Buy Stocks (Dec. 9)
FIGS, MDB, KMT, EVER and OPFI have been added to the Zacks Rank #1 (Strong Buy) List on December 9th, 2025.
What Makes Figs (FIGS) a Strong Momentum Stock: Buy Now?
Does Figs (FIGS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Figs (FIGS) Is Up 14.61% in One Week: What You Should Know
Does Figs (FIGS) have what it takes to be a top stock pick for momentum investors? Let's find out.
FIGS: Durable Growth In A Human-Driven Healthcare Apparel Niche
FIGS, Inc. stands out for its unique approach, focusing on fundamentals rather than AI-driven trends. The company emphasizes quality and innovation in its product offerings, targeting healthcare professionals with specialized apparel. FIGS' business model and brand loyalty contribute to steady revenue growth and customer retention.
Surging Earnings Estimates Signal Upside for Figs (FIGS) Stock
Figs (FIGS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Is FIGS (FIGS) Outperforming Other Retail-Wholesale Stocks This Year?
Here is how Figs (FIGS) and Kingfisher PLC (KGFHY) have performed compared to their sector so far this year.
FIGS, Inc. (FIGS) Q3 2025 Earnings Call Transcript
FIGS, Inc. ( FIGS ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants Tom Shaw - Senior Vice President of Investor Relations Catherine Spear - Co-Founder, CEO & Director Sarah Oughtred - Chief Financial Officer Conference Call Participants Robert Drbul - BTIG, LLC, Research Division Rakesh Patel - Raymond James & Associates, Inc., Research Division Brooke Roach - Goldman Sachs Group, Inc., Research Division Matt Koranda - ROTH Capital Partners, LLC, Research Division Brian Nagel - Oppenheimer & Co. Inc., Research Division Dana Telsey - Telsey Advisory Group LLC Ashley Owens - KeyBanc Capital Markets Inc., Research Division John Kernan - TD Cowen, Research Division Angus Kelleher-Ferguson - Barclays Bank PLC, Research Division Presentation Operator Good afternoon. Thank you for attending the FIGS Third Quarter Fiscal 2025 Earnings Conference Call.
Figs (FIGS) Reports Q3 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Figs (FIGS) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Finally Time To Buy FIGS Stock?
The stock of interface design software firm Figma (NYSE:FIG) has experienced a significant downturn, plunging almost 24% over the last month and is currently down more than 55% from the peak it achieved soon after its IPO in July. While such fluctuations are typical for newly listed companies, Figma's extraordinarily high valuation at the time of listing – trading at over 60 times forward sales – has exacerbated the subsequent decline.
FIGS, Inc. (FIGS) Presents At Goldman Sachs 32nd Annual Global Retailing Conference 2025 Transcript
FIGS, Inc. (NYSE:FIGS ) Goldman Sachs 32nd Annual Global Retailing Conference 2025 September 3, 2025 3:55 PM EDT Company Participants Sarah Oughtred - Chief Financial Officer Catherine Spear - Co-Founder, CEO & Director Conference Call Participants Brooke Roach - Goldman Sachs Group, Inc., Research Division Presentation Brooke Roach Research Analyst Good afternoon, and welcome to this next session of the GS 32nd Annual Global Retailing Conference. My name is Brooke Roach, and I cover the apparel brands and softline sector here at Goldman, and I'm very happy to introduce our next session with FIGS.
FIGS: U.S. Market Seems To Be Turning, But The Name Is Still Expensive
FIGS, Inc. delivered strong Q2 results with U.S. core scrubs demand rebounding and solid OpEx leverage, driving improved profitability. Guidance was raised for both revenue and margin, but management remains cautious on 2H25 due to tariffs and reduced promotional activity. International expansion is contributing meaningfully, but US growth remains the key driver amid ongoing headwinds in non-scrubwear and Canada.
